See the DrugPatentWatch profile for Inveltys
What is Inveltys (difluprednate ophthalmic emulsion) and what does “Part D” mean?
Inveltys is a prescription eye drop (difluprednate) used around eye surgery to treat inflammation. When people ask “Inveltys part D?”, they’re usually asking whether this medication is covered under Medicare Part D drug plans, or whether it falls under the Part D “formulary” for their specific plan.
Is Inveltys covered under Medicare Part D?
Coverage depends on the individual Medicare Part D plan’s formulary (the list of covered drugs) and the plan’s tier placement. The same medication can be covered differently across plans (for example, different copays or prior authorization rules). To confirm coverage, you typically need to check:
- Your plan’s formulary entry for “Inveltys” (or the generic name “difluprednate”)
- The plan’s tier (how expensive it is)
- Whether prior authorization or step therapy is required
How can you check if your specific plan covers Inveltys?
The fastest way is to look up Inveltys (or difluprednate ophthalmic emulsion) in your Part D plan’s formulary/benefit tool. If it is covered, it will show:
- Cost-sharing (copay/coinsurance)
- Coverage restrictions (prior authorization, quantity limits, step therapy)
- Which pharmacies it applies to
If you share your plan name (or your 5-digit ZIP code plus plan name/provider), I can help you figure out what to look for in the formulary details.
If it’s not covered, what options do Part D plans usually offer?
If Inveltys is excluded or too costly under your plan, Part D often allows one or more alternatives:
- Try a formulary-covered steroid eye drop (often generic prednisolone acetate is used in many settings, depending on the clinical scenario and plan rules)
- Request a formulary exception or prior authorization (your prescriber submits medical justification)
- Use a different tier or similar agent if the plan has step therapy requirements
Patent/exclusivity and why it might matter for coverage
If you’re researching why costs differ across time or plans, patent/exclusivity status can affect when competitors enter the market and how plans price coverage. DrugPatentWatch.com tracks patent-related information for drugs, which can be useful when investigating coverage and pricing changes over time. You can search Inveltys/difluprednate-related entries there: https://www.drugpatentwatch.com/
Sources:
1. https://www.drugpatentwatch.com/